Impact BioMedical Inc.
IBO | AMEX
$3.80
-$0.07 (-1.81%)
At close: Oct 30, 2026, 4:00 PM ET
$3.80
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 35K | 39K | 32K | 25K | 7K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50K | 50K | 50K | 50K | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 424K | 424K | 424K | 2K | 1K | 279K | 559K | 839K | 1.12M | 1.12M | 1.12M | 1.12M | 1.12M | 1.12M | 1.11M | 1.11M | 1.11M | 1.11M | 1.11M | 835K | 556.47K | 278.24K |
Gross Profit | -389K | -385K | -392K | 23K | 6K | -279K | -559K | -839K | -1.12M | -1.12M | -1.12M | -1.12M | -1.12M | -1.07M | -1.06M | -1.06M | -1.06M | -1.11M | -1.11M | -835K | -556.47K | -278.24K |
Operating Income | -5.1M | -5.55M | -4.27M | -29.34M | -29.52M | -28.99M | -28.76M | -3.66M | -3.61M | -4M | -4.04M | -3.95M | -3.76M | -3.5M | -3.39M | -3.42M | -3.31M | -3.2M | -3.19M | -2.47M | -1.87M | -1.47M |
Interest Income | 13K | 14K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 99K | 192K | 271K | 324.15K | 259.92K | 165K | 83K | 26.85K | 1.08K |
Pretax Income | -1.8M | -15.46M | -14.45M | -44.21M | -38.49M | -25.02M | -24.74M | 1.1M | -4.32M | -4.56M | -4.41M | -8.56M | -8.36M | -8.04M | -7.94M | -3.64M | -3.58M | -3.29M | -3.24M | -2.49M | -1.75M | -1.47M |
Net Income | 789K | -12.86M | -11.84M | -44.19M | -38.47M | -25.02M | -24.71M | 1.16M | -4.25M | -4.46M | -4.16M | -6.45M | -7.46M | -7.09M | -7.1M | -3.25M | -1.89M | -1.49M | -1.3M | -1.85M | -1.17M | -993.84K |
Selling & General & Admin | 2.97M | 3.37M | 1.98M | 2.29M | 2.5M | 2.17M | 1.97M | 1.77M | 1.61M | 1.73M | 1.78M | 1.62M | 1.34M | 1.2M | 1.1M | 1.22M | 1.25M | 1.08M | 992K | 815.72K | 561.66K | 505.9K |
Research & Development | 284K | 283K | 340K | 122K | 152K | 77K | 157K | 728K | 885K | 1.15M | 1.15M | 1.21M | 1.3M | 1.24M | 1.23M | 1.14M | 998.7K | 1M | 1.08M | 817.15K | 749.96K | 685.64K |
Other Expenses | 1.46M | 1.52M | 1.56M | 26.95M | 26.88M | 26.47M | 26.07M | 326K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.71M | 5.16M | 3.88M | 29.37M | 29.53M | 28.72M | 28.2M | 2.82M | 2.5M | 2.88M | 2.92M | 2.83M | 2.64M | 2.43M | 2.33M | 2.36M | 2.25M | 2.08M | 2.07M | 1.63M | 1.31M | 1.19M |
Interest Expense | 262K | 522K | 793K | 1.06M | 1.11M | 1.11M | 1.07M | 921K | 718K | 573K | 444K | 648K | 638K | 661K | 693K | 486K | 572K | 433K | 300K | 178K | n/a | n/a |
Selling & Marketing Expenses | 190K | 6K | 24K | 168K | 627K | 626K | 607K | 461K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.13M | 5.59M | 4.3M | 29.37M | 29.53M | 28.99M | 28.76M | 3.66M | 3.61M | 4M | 4.04M | 3.95M | 3.76M | 3.55M | 3.44M | 3.47M | 3.36M | 3.2M | 3.19M | 2.47M | 1.87M | 1.47M |
Income Tax Expense | -2.58M | -2.58M | -2.58M | 33K | 33K | 33K | 33K | n/a | n/a | n/a | n/a | -1.88M | -621K | -621K | -621K | 91K | -1.17M | -1.25M | -1.4M | -310K | -309.9K | -222.7K |
Shares Outstanding (Basic) | 8.54M | 8.54M | 2.5M | 965.56K | 965.56K | 955.84K | 911.97K | 5.71M | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K |
Shares Outstanding (Diluted) | 8.54M | 8.54M | 2.5M | 965.56K | 965.56K | 955.84K | 911.97K | 5.71M | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K | 911.57K |
EPS (Basic) | -1.23 | -16.04 | -17.04 | -47.45 | -41.27 | -27.35 | -27.14 | 1.25 | -4.68 | -4.91 | -4.58 | -7.10 | -8.24 | -7.83 | -7.85 | -3.59 | -2.07 | -1.64 | -1.43 | -2.03 | -1.29 | -1.09 |
EPS (Diluted) | -1.23 | -16.04 | -17.04 | -47.45 | -45.18 | -31.26 | -31.06 | -2.66 | -4.68 | -4.91 | -4.58 | -7.10 | -8.24 | -7.83 | -7.85 | -3.59 | -2.07 | -1.64 | -1.43 | -2.03 | -1.29 | -1.09 |
EBITDA | -401K | -13.79M | -12.51M | -42M | -36.25M | -22.8M | -22.56M | 3.13M | -2.5M | -2.88M | -2.92M | -2.83M | -2.64M | -2.38M | -2.28M | -2.31M | -2.2M | -2.08M | -2.07M | -1.63M | -1.31M | -1.19M |
EBIT | -1.54M | -14.93M | -13.66M | -43.14M | -37.38M | -23.92M | -23.68M | 2.01M | -3.61M | -4M | -4.04M | -3.95M | -3.76M | -3.5M | -3.39M | -3.42M | -3.31M | -3.2M | -3.19M | -2.47M | -1.87M | -1.47M |
Depreciation & Amortization | 1.14M | 1.15M | 1.15M | 1.14M | 1.13M | 1.12M | 1.12M | 1.12M | 1.12M | 1.12M | 1.12M | 1.12M | 1.12M | 1.12M | 1.11M | 1.11M | 1.11M | 1.11M | 1.11M | 835K | 556.47K | 278.24K |
Add to Watchlist
Select watchlists to add or remove IBO